Therapeutic Medicine Researcher And Executive Scott Rocklage

Scott Rocklage has spent many years in the healthcare field as a top executive of companies such as Cubist Pharmaceuticals, where he served as Chairman and CEO from 1994 to 2003. Being the inventor of more than 30 patents in the U.S., he has a deep passion for finding cures for the kinds of diseases that doctors have not been able to treat effectively. In his role at his current company, 5AM ventures, he helps finance research that will be used to fight conditions that are connected to the genetic disorder known as muscular dystrophy.


His responsibilities at 5AM Ventures, which is a California-based venture capital firm, involves working with medical entrepreneurs like scientists and doctors, and other business executives to help them turn their ideas into drug therapies that can treat or cure certain health conditions that are harder to tackle. He joined the company in 2003, and a year later became its Managing Partner. The firm was founded in 2002, and it specializes in offering early stage investments to its clients.


Scott Rocklage attended the University of California at Berkeley, where he earned a BS degree in Chemistry, and he later went to the Massachusetts Institute of Technology and received a PhD in the same major. While at MIT, he studied under chemistry professor Richard R. Schrock, who is a Nobel Prize winner. In addition to attending to all of his other duties, he has also written and published more than 100 peer-reviewed research papers, and he is a member of the Board of Associates at a non-profit biomedical research foundation called Whitehead Institute.


His experience in healthcare management spans 3 decades, and he’s said that his achievements can be credited to the fact that he has always pushed himself to keep learning and growing, and to not be afraid to take risks. He continues to have a big interest and focus on researchers finding a way to target specific gene mutations that will allow doctors to treat major diseases such as cancer in alternative ways. He feels that this will extend people’s lives, and he looks forward to seeing this method improve in the future.


Visit to learn more.


Author: CDG1976

Leave a Reply

Your email address will not be published. Required fields are marked *